Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Assets Average (2024 - 2025)

Historic Assets Average for CG Oncology (CGON) over the last 2 years, with Q3 2025 value amounting to $715.7 million.

  • CG Oncology's Assets Average rose 2816.59% to $715.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $715.7 million, marking a year-over-year increase of 2816.59%. This contributed to the annual value of $477.0 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, CG Oncology's Assets Average stood at $715.7 million, which was up 2816.59% from $714.8 million recorded in Q2 2025.
  • CG Oncology's Assets Average's 5-year high stood at $741.5 million during Q1 2025, with a 5-year trough of $389.2 million in Q1 2024.